Trials / Withdrawn
WithdrawnNCT05505071
DANTE SPACE for Evaluation of Subjects With Intracranial Vascular Disease
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of North Carolina, Chapel Hill · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Purpose: The purpose of this study is to evaluate the Delay Alternating with Nutation for Tailored Excitation (DANTE) SPACE sequence in clinical studies to determine whether it can provide more useful information for clinical diagnosis. Participants: 100 participants with concern for intracranial vascular disease scheduled to undergo a clinical vessel wall MRI will be recruited. Procedures (methods): Patients with concern for intracranial vascular disease scheduled to undergo a clinical vessel wall MRI who will have an additional non-FDA approved sequence (DANTE SPACE) added to their clinical scan. The investigational sequence requires less than 15 minutes and will be added following the standard MRI sequence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DANTE SPACE sequence | investigational MRI sequence less than 15 minutes |
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2022-08-17
- Last updated
- 2023-01-05
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05505071. Inclusion in this directory is not an endorsement.